Top Software Companies (10,000+)

Cost & Operational Efficiency: Adjusted EBITDA and margins expanded through late 2025 into 2026 even as revenue softened, reflecting disciplined monetization and cost control. A growing direct-to-consumer channel lowers platform fees and supports stronger unit economics.

Diversified Revenue Streams: The direct-to-consumer channel became a larger share of segment revenue across 2025–2026. This channel mix shift broadens monetization pathways and strengthens direct player relationships.

Strong Market Position & Advantage: Flagship titles posted recurring record revenues in late 2025, and key titles frequently sit near the top of U.S. casino grossing charts. Management also highlighted periods of outpacing the broader social casino market and repeated industry awards, indicating category leadership.

Investor Backing & Capital Strength: A $300M growth investment from Vista Equity Partners in January 2022 is presented as fueling expansion. Subsequent acquisitions (e.g., eVideon in 2025) and ongoing product releases indicate that this capital is being deployed to scale the business.

Product Line Growth: The company moved beyond secure messaging with 2026 launches like an AI‑powered Operator Console and a broader “Winter 2026” release, and it added smart room/patient‑engagement capabilities via the 2025 eVideon acquisition. These steps reflect a push into enterprise care‑orchestration workflows spanning operator, alarms, and in‑room experiences.

Strong Market Position & Advantage: Independent industry trackers list TigerConnect with a leading customer score on KLAS’ 2025 Clinical Communications page, signaling strong outcomes relative to peers. Visibility on the Inc. 5000 (e.g., 2023, with a stated 2026 inclusion) further suggests durable commercial traction among private firms.

Strong Revenue Growth: Recent results show full-year 2025 revenue of about $3.05B up roughly 6% year over year, with Q1 2026 up 7.5% and Q2 2026 up ~5% year over year alongside mid‑single‑digit organic gains. Consistent quarterly execution through 2025 underscores steady top‑line momentum.

Profitability: Management reported record revenue with “impressive margin expansion” in Q2 2026, and adjusted EBITDA margin expanded earlier in 2026. Strong operating cash generation in 2025 further supports the improving earnings profile.

Innovation-Driven Growth: New launches such as AI‑enabled sustainability software (ULTRUS 360), building‑compliance software, and certifications for AI‑enabled products and hydrogen fueling components indicate investment in adjacent, faster‑growing niches. These moves align the portfolio with regulation‑ and sustainability‑driven demand.

Strong Revenue Growth: Galleri and total revenue have risen consistently, with full-year 2025 up 17% and U.S. Galleri up 26%, followed by Q1–Q2 2026 total revenue gains of 28% and 26% alongside 50% and 35% volume growth. This cadence, including Q4 2025 Galleri revenue up 31%, indicates sustained commercial momentum after the June 2024 spin‑off.

Strategic Partnerships: Channel and platform integrations such as Epic EHR and Quest Diagnostics, plus collaborations like Samsung for Asian commercialization, are expanding access and streamlining ordering. Additional distribution wins (e.g., Priority Health employer plans and digital health channels) reinforce multi‑channel penetration for Galleri.

Investor Backing & Capital Strength: The company reports a substantial cash balance (~$861.6M as of Q2 2026) and closed a $110M equity financing with Samsung, bolstering financial flexibility. Public listing post‑spin‑off further enhances capital‑markets access to fund trials and commercialization.

Strong Revenue Growth: Revenue is advancing at a strong double‑digit pace with Cloud accelerating, while forward indicators like ARR and contracted backlog are also expanding, pointing to durable top‑line momentum.

Innovation-Driven Growth: AI-led capabilities (e.g., Rovo) and deeper platform adoption are tied to higher monetization and faster ARR expansion among adopters, reinforcing product-led growth.

Customer Loyalty & Retention: Cloud net revenue retention remains well above 100% and has improved over successive quarters, suggesting healthy expansion within the existing customer base.

Investor Backing & Capital Strength: A new $10 million raise in July 2026, described as part of a $30M+ round, alongside recent SEC filings indicates continued capital formation to fund expansion and hiring. Prior institutional backing provides runway to execute growth plans.

Strong Hiring & Retention: The company’s Greenhouse jobs board lists current openings in peer support and outreach roles, signaling active headcount additions rather than a freeze. Continued expansion of these roles would demonstrate that growth plans are being operationalized.

Market Expansion: The company’s site shows operations across Florida, Ohio, Michigan, Virginia, and Washington, evidencing a multi‑state footprint with room to deepen as funding allows. Active recruiting across these states supports ongoing build‑out.

Strong Revenue Growth: Revenue accelerated across early 2026, with Q2 performance surpassing guidance and prompting management to raise the full‑year outlook to around $1 billion of revenue and higher adjusted EBITDA. Guidance increases followed multi‑quarter momentum from 2025 into 2026.

Diversified Revenue Streams: Media Technology grew sharply with stronger advertising demand and the Legend acquisition, while expansion into prediction markets adds a new category beyond core betting data. This mix shift broadens exposure beyond a single segment and supports the higher full‑year targets.

Innovation-Driven Growth: New offerings such as GeniusIQ, Moment Engine, and BetVision—alongside price‑led renewals and expanded services in Betting Technology—are identified as key drivers of segment gains. Product momentum in ad tech and data‑rich streaming is contributing meaningfully to growth.

Profitability: Non‑GAAP operating income and net income increased year over year in 1H 2026, and the company lifted its exit‑Q4 2026 operating margin target to about 17%. Guidance also outlines a Rule‑of‑40 target of 30% by Q4 2027, indicating continued focus on margin expansion.

Healthy Cash Flow: Non‑GAAP free cash flow reached $24.7M in Q1 2026 and remained positive in Q2, pointing to improved cash generation. These trends support ongoing investment without straining liquidity.

Innovation-Driven Growth: The launch of an AI‑powered social intelligence platform and expansion of the Trellis AI agent in 2026 are positioned to support upmarket expansion. Growth in larger ARR cohorts and rising RPO provide evidence that product advances are aligning with enterprise adoption.

Strong Revenue Growth: Outset reported 8x revenue growth during 2025, with earlier statements citing nearly 20% month-over-month revenue gains and a 10x increase in customer usage. These time-stamped disclosures point to rapid top-line acceleration.

Investor Backing & Capital Strength: Outset announced a $17M Series A on June 11, 2025 and a $30M Series B on December 10, 2025, bringing disclosed funding to $51M. The quick A-to-B cadence indicates ample capital and investor conviction to scale.

Market Expansion: Public materials highlight a growing enterprise footprint with customers such as Microsoft, WeightWatchers, Nestlé, Uber, and HubSpot, alongside an expansion from AI-moderated research into an AI-native CXM platform. These developments suggest wider adoption and a broadened addressable market.

Strong Revenue Growth: Unanet reported double‑digit revenue growth for full‑year 2025, citing product innovation and new customer wins across GovCon and AEC. Continued inclusion on the Inc. 5000 in 2025–2026 aligns with multi‑year revenue expansion.

Innovation-Driven Growth: The company rolled out agentic AI across ERP and CRM (e.g., Wyatt/Champ agents and GrowthStudio), with broader availability announced in July 2026. Company updates connect these launches to ongoing adoption and Q2 2026 momentum.

Market Expansion: International reach advanced via a U.K. launch of Construction CRM through a partnership with Algorithms Software UK alongside steady streams of new wins and competitive replacements. Progress toward FedRAMP readiness and later Moderate Equivalency in early 2026 broadened opportunities in GovCon.

Strong Revenue Growth: Revenue is reported to have risen from £169.4m in 2023 to £197.0m in 2024, based on filed UK statutory accounts. Parent-company commentary for 2025 further points to higher “Other revenues” tied to this unit, reinforcing the upward trend.

Profitability: Operating profit increased to £45.9m in 2024 alongside higher profit after tax, indicating improved operating leverage. These gains are documented in UK filings as summarized by industry coverage.

Market Expansion: Customer milestones include surpassing one million globally in 2024 and one million in the UK in 2026, while a new Boston headquarters signals continued U.S. investment. Recent product and initiative rollouts (e.g., AI tools and community programs) indicate ongoing expansion efforts.

Investor Backing & Capital Strength: A third funding round reported as a Series C in June 2024, bringing total raised to $200M+, is presented as a scaling‑stage milestone and foundation for continued investment. This capital base aligns with ongoing product rollouts and market expansion efforts.

Strategic Partnerships: Cleveland Clinic expanded its enterprise deployment in 2025, and the Clinic’s own materials later highlighted systemwide use of AKASA’s generative‑AI tools for coding and documentation across U.S. locations. These multi‑site, referenceable wins indicate traction with major health systems.

Product Line Growth: Successive mid‑cycle launches in 2024–2025 (e.g., Authorization Advisor, AKASA Medical Coding, CDI Optimizer) highlight continued R&D and commercialization. This expansion signals a broader roadmap beyond an initial single‑product focus.

Strategic Partnerships: New relationships with firms such as Fidelity, Capital Group, Vanguard, and client wins like Elevation Point broaden distribution and embed the platform within major advisor ecosystems. These selections signal expanding access to workflows across large wealth programs.

Innovation-Driven Growth: Launches such as Vestmark Pulse and the opening of a Center for AI Research and Development indicate continued investment in AI-enabled capabilities. Growth in VAST and expanded tax-aware UMA features reinforce a steady cadence of new solutions.

Strong Market Position & Advantage: Scale of more than $2 trillion in assets on platform, millions of accounts, and support for 72,000+ advisors points to broad institutional adoption. Serving six of the ten largest managed-account platforms and VAS crossing $50B in AUM add evidence of an entrenched position at the high end of the market.

Strong Revenue Growth: North America net revenue is reported as having grown year over year in 2025, supported by a full‑year contribution from Instant Win Gaming and record performance highlighted in Illinois. Company materials also emphasize a multi‑year trajectory of strategic progress and an expanding North American platform.

Market Expansion: The majority acquisition of PrizePicks in January 2026 and the earlier IWG acquisition broaden the U.S. footprint beyond lottery operations into daily fantasy sports and deepen eInstant content for lotteries. Illinois operations and continued iLottery growth further extend reach across jurisdictions and product types.

Diversified Revenue Streams: Adding PrizePicks and IWG diversifies the region’s mix beyond a single operating contract, bringing DFS and content/technology revenues alongside lottery operations. This combination is positioned to support growth across operations, content, and digital channels through 2025–2026.

Strategic Partnerships: Partnerships with large RIAs—including EP Wealth Advisors, Mercer Advisors, Summit Financial, Venturi Private Wealth, Fidelis Capital, and others—are widening distribution in the advisor channel focused on private markets. Ongoing visibility on partner sites reinforces that these relationships are active and externally promoted.

Product Line Growth: Platform capabilities expanded with 2023 “custom funds” and later with new vehicles like a 2026 AI‑focused venture fund, alongside end‑to‑end workflows and planning/diligence tools. This breadth signals a maturing product footprint serving more advisor use cases.

Strong Hiring & Retention: Headcount has increased and a VP of Sales & Revenue (a CAIS veteran) was hired in February 2026 to commercialize AI‑enabled diligence and deepen RIA relationships. These moves indicate organizational investment to scale go‑to‑market and client success.

Investor Backing & Capital Strength: Major raises—including a $60M Series C (2019), $300M Series D (2019), and $300M Series E (2021) at a $2.9B valuation—signal deep funding capacity to support product launches, acquisitions, and market pushes. Earlier totals around $750M+ are cited as enabling initiatives like the Codeco‑Vanoco acquisition and platform expansion.

Product Line Growth: Rollouts of an energy‑specific source‑to‑pay/Vendor Management platform and Bid Management, plus a new technology‑licensing line via Shell’s U‑lateral drilling technology, broaden revenue avenues beyond staffing. The shift toward a software‑and‑services stack points to higher‑margin growth options.

Strong Market Position & Advantage: Within energy workforce and vendor management, the company is portrayed as a leading specialist with wide adoption among major operators and a large network. Historical scale signals (e.g., millions of billed hours and strong presence across U.S. basins) underpin continued opportunity in its core niche.

Innovation-Driven Growth: New AI-focused capabilities (e.g., AI Connectors built on Model Context Protocol) and a stated push to be an “AI platform for biotech R&D” signal ongoing product investment. Reported usage of Benchling AI across 500 biotech companies underscores adoption of these innovations.

Strategic Partnerships: The January 2026 collaboration with Lilly’s TuneLab is positioned to bring proprietary models to scientists across Benchling’s customer base. Acqui-hires of ReSync Bio and Sphinx Bio in 2025 were used to accelerate the AI roadmap.

Strong Revenue Growth: ARR was independently estimated around the low-$200 millions by mid-2024 with year-over-year increases, indicating continued top-line expansion. While the pace has moderated versus earlier years, the trajectory remains positive.

Investor Backing & Capital Strength: Recent capital raises include a $56.1M Series C in July 2024 and additional growth financing in March 2026 to expand product, sales, and customer success. These transactions point to strong investor support and resources to scale.

Product Line Growth: New and enhanced offerings such as the Group Health Risk Management Life Cycle (Sept 2025) and workers’ comp tools like ClaimVector and a 2026 triage solution indicate active product development. This expansion supports broader use cases across underwriting and claims.

Strong Revenue Growth: Company communications highlight double‑digit year‑over‑year growth since founding and well over 100% growth exiting 2022, with a later 50% YoY increase in platform volume. These signals suggest ongoing commercial momentum.

Strong Revenue Growth: Revenue and ARR are expanding rapidly at scale, with Q1 FY27 revenue near $479M and ARR approaching $2B while full‑year guidance still calls for further growth. Continued expansion among $100K+ and $1M+ customer cohorts reinforces momentum.

Profitability: The company reports consecutive GAAP‑profitable quarters alongside improving non‑GAAP operating and free‑cash‑flow margins, indicating operating leverage. Management also expects GAAP profitability for the full FY27.

Innovation-Driven Growth: New products such as AI Multicam, Asset Maintenance, Asset Tags, Connected Training, and Connected Workflows are contributing materially to net new ACV and deepening multi‑product adoption. A large and growing data platform and interest in Operational AI further catalyze expansion.

Investor Backing & Capital Strength: The June 2025 definitive agreement for acquisition by STG, with leadership continuity noted at announcement and a sizable employee footprint, points to a platform investment with resources to scale. Earlier unicorn-level financing further underscores access to capital supporting ongoing expansion.

Innovation-Driven Growth: Regular releases through late 2025 and 2026—such as Da Vinci enhancements and the launch of Programmatic CRM with AI/agentic capabilities—signal sustained R&D and product momentum. Feature and suite expansion across email, mobile, and web indicate a growth engine rooted in innovation.

Strong Hiring & Retention: Mid-2026 career pages and third-party trackers show active open roles and “we’re hiring” messaging, implying continued team expansion. Public materials reference a global workforce across multiple regions, consistent with selective growth.